Hrabálek L, Machác J, Vaverka M
Neurochirurgická klinika FN a LF UP Olomouc.
Acta Chir Orthop Traumatol Cech. 2009 Oct;76(5):417-23.
Each dynamic stabilisation should preserve motion at the operated segment as well as reduce a load on the disc and intervertebral joints. One of the methods to achieve this is the implantation of interspinous spacers between lumbar spinous processes. In this study, the patients treated with the DIAM interspinous spacer (Medtronic, USA) were prospective- ly followed up with the aim to evaluate clinical outcomes and post-operative complications.
Patients with a degenerative disease of the lumbosacral spine were indicated for the operation. They suffered from axial pain with signs of nerve root involvement due to disc hernia, foraminal stenosis or disc herniation recurrence A total of 68 patients aged 23 to 75 (average age, 50.01) years, including 39 men (average age, 50.44) and 29 women (average age, 49.45), were followed up for 1 to 3 years and evaluated.
All patients underwent a standard pre-operative clinical and neurological examination. Each patient assessed pain intensity using a Visual Analogue Scale (VAS) and, with an Oswestry Disability Index (ODI) questionnaire, evaluated their functional state. In the case of disc hernia or disc herniation recurrence, a sequester was removed; for foraminal stenosis, foraminotomy and partial medial facetectomy was performed. After this decompression of nerve structures, a spacer was implanted. Follow-up included clinical and neurological examination at 6 weeks, 6 months and 1 - 3 years post-operative- ly. At 6 months and between 1 and 3 years after surgery, pain intensity and functional outcome using VAS and ODI assessments were measured by the patients, and antero-posterior and lateral skiagrams of the lumbosacral spine were made. The X-ray examination was made to reveal a potential implant dislocation. The VAS and ODI values at 1-3 post-operative years were compared with those before surgery and the results were statistically analysed. The surgeon evaluated the outcomes at 1-3 years of follow-up according to the Odom criteria.
The average ODI of the group was 60.44 % before and 21.85 % after surgery, which showed an improvement by 63.85%. The average VAS was 7.18 points before and 2.10 points after surgery, showing an improvement by 70.75 %. A comparison of the pre- and post-operative results showed, in the average ODI differences of 38.24 % and 39.44 % in women and men, respectively; and in the average VAS value, 5.00 in women and 5.19 in men. The results evaluated according to indication for surgery were as follows: in patients with disc hernia, the difference in ODI was 39.62 % on average, and in VAS it was 5.42 points on average. In patients with disc herniation recurrence, the differences between pre- and post-operative average values were 41.50 % for ODI and 5.00 points for VAS. In patients treated for foraminal stenosis, these differences were 39.79 % for ODI and 5.18 points for VAS. The results for the level treated showed that at L5/S1 the average difference for ODI was 46.75 % and 4.50 points for VAS ; at L4/5 it was 35.52 % for ODI and 5.12 for VAS; at L3/4 it was 48.00 % for ODI and 5.78 for VAS; and at L2/3 it was 39.00 % for ODI and 4.50 for VAS.The results related to the method of nerve root decompression included the average differences of 40.00 % in ODI and 5.17 in VAS for removal of a disc sequester; and average differences of 32.89 % in ODI and 4.78 in VAS for foraminotomy and partial medial facetectomy. The results evaluated for the duration of pre-operative complaints were as follows: surgery by 3 months, average ODI, 44, 53 % and average VAS, 5.25; surgery between 3 and 6 months, average ODI, 37.65 % and average VAS, 4.71; and surgery after 6 months, average ODI, 35.60 % and average VAS, 5.28. The Odom criteria showed results as excellent in 41 %, good in 51.5 % and fair in 7.5 % of the patients. No poor result was recorded. There were no early complications such as haematoma, wound seroma or deep subfascial infection, and no implant dis- location. One patient had to undergo repeat surgery for subcutaneous infection without affecting the implant. Until the end of the study, no signs of herniation recurrence at the segment stabilised with a Diam interspinous spacer had been found.
The fact that none of the patients in this study required revision surgery or had a recurrence of disc herniation provides evidence for the effectiveness of the DIAM interspinous spacer.This also suggests that the implant protects the whole operated spinal segment, i.e., both intervertebral joints and discs, from being overloaded. Lesser mechanical stress applied to intervertebral facets may slow down degenerative processes and reduce their signs.
The implantation of a DIAM interspinous spacer is a less invasive and safe method of dynamic stabilisation of the spi- ne without intra- or post-operative complications that is well tolerated by the patient. At 3-year follow-up the patients reported improvement in their functional state, as measured with an ODI, by 64 % on the average. Their axial and nerve root pain was reduced by 71 % on the average. All patients showed improved clinical conditions and the outcomes were evaluated as excellent in 41 %, good in 51 % and fair in 7.5 % of the patients. The results of implantation were not significantly related to age, gender, operative indications, operated lumbosacral level, method of nerve root decompression or duration of pre-operative problems. No patient treated by the DIAM spacer had any recurrence of disc herniation.
每种动态稳定术都应保留手术节段的运动功能,同时减轻椎间盘和椎间关节的负荷。实现这一目标的方法之一是在腰椎棘突间植入棘突间间隔器。在本研究中,对接受DIAM棘突间间隔器(美国美敦力公司)治疗的患者进行前瞻性随访,旨在评估临床疗效和术后并发症。
患有腰骶部退行性疾病的患者被纳入手术治疗。他们因椎间盘突出、椎间孔狭窄或椎间盘突出复发而出现轴向疼痛并伴有神经根受累的体征。共有68例年龄在23至75岁(平均年龄50.01岁)的患者,其中男性39例(平均年龄50.44岁),女性29例(平均年龄49.45岁),接受了1至3年的随访并进行评估。
所有患者均接受标准的术前临床和神经学检查。每位患者使用视觉模拟量表(VAS)评估疼痛强度,并通过Oswestry功能障碍指数(ODI)问卷评估其功能状态。对于椎间盘突出或椎间盘突出复发的情况,摘除游离体;对于椎间孔狭窄,进行椎间孔切开术和部分内侧关节突切除术。在对神经结构进行减压后,植入间隔器。随访包括术后6周、6个月以及1至3年时的临床和神经学检查。在术后6个月以及1至3年时,患者使用VAS和ODI评估测量疼痛强度和功能结果,并拍摄腰骶部脊柱的前后位和侧位X线片。进行X线检查以发现潜在的植入物脱位。将术后1至3年的VAS和ODI值与术前进行比较,并对结果进行统计学分析。外科医生根据Odom标准评估随访1至3年的结果。
该组患者术前平均ODI为60.44%,术后为21.85%,改善率为63.85%。术前平均VAS为7.18分,术后为2.10分,改善率为70.75%。术前和术后结果比较显示,女性和男性的平均ODI差异分别为38.24%和39.44%;女性和男性的平均VAS值分别为5.00和5.19。根据手术指征评估的结果如下:椎间盘突出患者的ODI平均差异为39.62%,VAS平均差异为5.42分。椎间盘突出复发患者术前和术后平均值的差异为ODI 41.50%,VAS 5.00分。接受椎间孔狭窄治疗的患者,ODI差异为39.79%,VAS差异为5.18分。治疗节段的结果显示,在L5/S1节段,ODI平均差异为46.75%,VAS为4.50分;在L4/5节段,ODI为35.52%,VAS为5.12;在L3/4节段,ODI为48.00%,VAS为5.78;在L2/3节段,ODI为39.00%,VAS为4.50。与神经根减压方法相关的结果包括:摘除椎间盘游离体时ODI平均差异为40.00%,VAS为5.17;椎间孔切开术和部分内侧关节突切除术时ODI平均差异为32.89%,VAS为4.78。根据术前症状持续时间评估的结果如下:手术时间在3个月以内,平均ODI为44.53%,平均VAS为5.25;手术时间在3至6个月之间,平均ODI为37.65%,平均VAS为4.71;手术时间在6个月以后,平均ODI为35.60%,平均VAS为5.28。根据Odom标准,41%的患者结果为优,51.5%为良,7.5%为可。未记录到差的结果。没有出现早期并发症,如血肿、伤口血清肿或深部筋膜下感染,也没有植入物脱位。1例患者因皮下感染接受了再次手术,但未影响植入物。直到研究结束,在使用Diam棘突间间隔器稳定的节段未发现椎间盘突出复发的迹象。
本研究中没有患者需要翻修手术或出现椎间盘突出复发,这为DIAM棘突间间隔器的有效性提供了证据。这也表明该植入物可保护整个手术的脊柱节段,即椎间关节和椎间盘,使其免受过载影响。施加于椎间小关节的机械应力较小可能会减缓退变过程并减轻其症状。
植入DIAM棘突间间隔器是一种侵入性较小且安全的脊柱动态稳定方法,术中及术后均无并发症,患者耐受性良好。在3年随访时,患者报告其功能状态平均改善64%(通过ODI测量)。其轴向和神经根疼痛平均减轻71%。所有患者的临床状况均有所改善,41%的患者结果为优,51%为良,7.5%为可。植入结果与年龄、性别、手术指征、手术的腰骶节段、神经根减压方法或术前问题持续时间均无显著相关性。接受DIAM间隔器治疗的患者均未出现椎间盘突出复发。